Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease
Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S
Molecular Neurodegeneration · 2022
Key finding
There is strong increasing evidence supporting a role for the gut microbiome in the pathogenesis of Alzheimer's disease, including effects on synaptic dysfunction and neuroinflammation, which contribute to cognitive decline.
- Condition
- Alzheimer's Disease
- Stimulation
- iVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Bairamian, D., Sha, S., Rolhion, N., Sokol, H., Dorothée, G., Lemere, C. A., & Krantic, S. (2022). Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease. Molecular Neurodegeneration, 17(1). https://doi.org/10.1186/s13024-022-00522-2
Related studies in Alzheimer's Disease
Advances in VNS efficiency and mechanisms of action on cognitive functions
Wang et al. · Frontiers in physiology · 2024 · Systematic Review / Meta-Analysis
Locus coeruleus fMRI response to transcutaneous auricular vagus nerve stimulation is coupled to changes in salivary alpha amylase
Schneider et al. · Brain stimulation · 2025 · Controlled Clinical Trial
A vagal route to memory: evidence from invasive and non-invasive electrical vagus nerve stimulation studies and areas for future clinical application
Szeska et al. · Frontiers in human neuroscience · 2025 · Controlled Clinical Trial
Vagus Nerve Stimulation for Improvement of Vascular Cognitive Impairment
E et al. · Neuropsychiatric disease and treatment · 2024 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.